Aethlon Medical, Inc.
AEMD
$1.71
-$0.10-5.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 44.85% | 46.58% | -20.54% | 0.10% | -9.40% |
| Total Depreciation and Amortization | -4.63% | 16.58% | -25.68% | -16.30% | 15.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.89% | -90.58% | 925.17% | 421.09% | 365.06% |
| Change in Net Operating Assets | -61.66% | -893.91% | -3,007.77% | -249.79% | -210.67% |
| Cash from Operations | 5.69% | 8.46% | 18.95% | 20.76% | 18.97% |
| Capital Expenditure | -- | -- | 107.04% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 107.04% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 161.58% | -14.60% | 110.54% | 32.29% | -34.33% |
| Repurchase of Common Stock | 47.92% | 42.33% | 44.83% | 26.67% | 39.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.18% | 8.39% | -- | -- | -- |
| Cash from Financing | 256.17% | -15.60% | 67.76% | 8.80% | -58.08% |
| Foreign Exchange rate Adjustments | 167.80% | 153.28% | -24.79% | -454.93% | -3,033.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.08% | -780.46% | 168.08% | 70.01% | -38.46% |